Letter to the Editor
Split Viewer
Blood Res 2015; 50(2):
Published online June 25, 2015
https://doi.org/10.5045/br.2015.50.2.114
© The Korean Society of Hematology
Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation
1Division of Hematology and Medical Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological Sciences, Seoul, Korea.
2Department of Laboratory Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological Sciences, Seoul, Korea.
Correspondence to : Correspondence to Dong-Yeop Shin. Division of Hematology and Medical Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, 75 Nowon-gil, Nowon-gu, Seoul 139-706, Korea. baramg@hanmail.net
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PDF
Standard view
Export citation
Share Article
Letter to the Editor
Blood Res 2015; 50(2): 114-117
Published online June 25, 2015 https://doi.org/10.5045/br.2015.50.2.114
Copyright © The Korean Society of Hematology.
Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation
Dong-Yeop Shin1*, Hyo-Rak Lee1, Hye Jin Kang1, Im Il Na1, Yoon Hwan Chang2, and Sung Hyun Yang1
1Division of Hematology and Medical Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological Sciences, Seoul, Korea.
2Department of Laboratory Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological Sciences, Seoul, Korea.
Correspondence to: Correspondence to Dong-Yeop Shin. Division of Hematology and Medical Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, 75 Nowon-gil, Nowon-gu, Seoul 139-706, Korea. baramg@hanmail.net
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig 1.
Download
Flowchart of patient selection. Abbreviation: aPTT, activated partial thromboplastin time.
-
Baseline characteristics. Abbreviation: aPTT, activated partial thromboplastin time..
-
Results of coagulation factors of the intrinsic pathway. Abbreviations: IQR, Interquartile range; vWF:Ag, von Willebrand factor antigen; vWF:RCo, von Willebrand factor ristocetin cofactor..
Previous Article
